Neoplastic B-cell growth is impaired by HLA-G/ILT2 interaction

被引：0
|
作者：
A Naji
C Menier
G Maki
E D Carosella
N Rouas-Freiss
机构：
[1] CEA,
[2] Institut des Maladies Emergentes et des Therapies Innovantes (iMETI),undefined
[3] Service de Recherche en Hemato-Immunologie (SRHI),undefined
[4] Hopital Saint-Louis,undefined
[5] Univ Paris Diderot,undefined
[6] Sorbonne Paris Cite,undefined
[7] UMR E_5 Institut Univ.Hematologie,undefined
[8] Hopital Saint Louis,undefined
来源：
Leukemia | 2012年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1889 / 1892
页数：3
相关论文
共 50 条
  • [31] Co-expression of ILT4/HLA-G in human non-small cell lung cancer correlates with poor prognosis and ILT4-HLA-G interaction activates ERK signaling
    Zhang, Yanwen
    Zhao, Jianqiang
    Qiu, Lijun
    Zhang, Pei
    Li, Juan
    Yang, Dong
    Wei, Xiaojuan
    Han, Yali
    Nie, Siyue
    Sun, Yuping
    TUMOR BIOLOGY, 2016, 37 (08) : 11187 - 11198
  • [32] HLA-G and MHC Class II Protein Expression in Diffuse Large B-Cell Lymphoma
    Jesionek-Kupnicka, Dorota
    Bojo, Marcin
    Prochorec-Sobieszek, Monika
    Szumera-Cieckiewicz, Anna
    Jablonska, Joanna
    Kalinka-Warzocha, Ewa
    Kordek, Radzislaw
    Mlynarski, Wojciech
    Robak, Tadeusz
    Warzocha, Krzysztof
    Lech-Maranda, Ewa
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2016, 64 (03) : 225 - 240
  • [33] HLA-G and MHC Class II Protein Expression in Diffuse Large B-Cell Lymphoma
    Jesionek-Kupnicka, Dorota
    Bojo, Marcin
    Prochorec-Sobieszek, Monika
    Szumera-Cieckiewicz, Anna
    Jablonska, Joanna
    Kalinka-Warzocha, Ewa
    Kordek, Radzislaw
    Mlynarski, Wojciech
    Robak, Tadeusz
    Warzocha, Krzysztof
    Lech-Maranda, Ewa
    BLOOD, 2014, 124 (21)
  • [34] Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/ILT-4/FasL-mediated pathways
    Naji, Abderrahim
    Durrbach, Antoine
    Carosella, Edgardo D.
    Rouas-Freiss, Nathalie
    HUMAN IMMUNOLOGY, 2007, 68 (04) : 233 - 239
  • [35] AUTOCRINE CONTROL OF HUMAN NEOPLASTIC B-CELL GROWTH
    FORD, RJ
    KWOK, D
    OWESADA, J
    SAHASRABUDDHE, CG
    FEDERATION PROCEEDINGS, 1985, 44 (04) : 909 - 909
  • [36] Differential expression of HLA-G and ILT-2 receptor in human tuberculosis: Localized versus disseminated disease
    Saurabh, Abhinav
    Thakral, Deepshi
    Mourya, Manish K.
    Singh, Amar
    Mohan, Anant
    Bhatnagar, Anuj K.
    Mitra, Dipendra K.
    Kanga, Uma
    HUMAN IMMUNOLOGY, 2016, 77 (09) : 746 - 753
  • [37] The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma
    Marcela García
    Maria Belen Palma
    Jerome Verine
    Santiago Miriuka
    Ana M. Inda
    Ana L. Errecalde
    François Desgrandchamps
    Edgardo D. Carosella
    Diana Tronik-Le Roux
    BMC Cancer, 20
  • [38] The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma
    Garcia, Marcela
    Palma, Maria Belen
    Verine, Jerome
    Miriuka, Santiago
    Inda, Ana M.
    Errecalde, Ana L.
    Desgrandchamps, Francois
    Carosella, Edgardo D.
    Tronik-Le Roux, Diana
    BMC CANCER, 2020, 20 (01)
  • [39] Dimerization of Soluble HLA-G by IgG-Fc Fragment Augments ILT2-Mediated Inhibition of T-Cell Alloresponse
    Zhang, Maohua
    Weng, Xiufang
    Liang, Zhihui
    Lu, Shengjun
    Li, Jianan
    Chen, Xueling
    Li, Qing
    Sun, Wei
    Song, Yinhong
    Shen, Guanxin
    Wu, Xiongwen
    TRANSPLANTATION, 2009, 87 (01) : 8 - 15
  • [40] CD8+ and CD56+ cutaneous lymphomas express HLA-G and killer cell inhibitory ligand, ILT-2
    Urosevic, M
    Kamarashev, J
    Kempf, W
    Burg, G
    Dummer, R
    TISSUE ANTIGENS, 2003, 62 (04): : 352 - 352
12345